M. Takeuchi

发表

Osteoclasts are involved in the maintenance of dormant leukemic cells.

S. Kimura, J. Kuroda, A. Yokota, 2009, Leukemia research.

Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells.

S. Kimura, M. Reule, J. Lyons, 2010, Blood.

ABT‐737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug‐resistance mechanisms

A. Strasser, M. Andreeff, M. Taniwaki, 2007, British journal of haematology.

Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/β-catenin signaling inhibitor.

J. Strovel, Y. Hayashi, H. Hirai, 2011, Cancer letters.

Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface.

M. Taniwaki, S. Kimura, J. Kuroda, 2007, Biochemical and biophysical research communications.

Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr‐Abl positive leukemic cells

Y. Hayashi, H. Hirai, S. Kimura, 2011, Cancer science.

β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model

M. Taniwaki, S. Kimura, J. Kuroda, 2009, Clinical Cancer Research.

Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

A. Strasser, M. Andreeff, M. Taniwaki, 2007, Cell Death and Differentiation.

Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment

T. Tsuruo, S. Kimura, J. Kuroda, 2010, Cell Death and Differentiation.

Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model

S. Kimura, T. Habuchi, N. Tsuchiya, 2009, Cancer Immunology, Immunotherapy.

Galectin‐9 ameliorates acute GVH disease through the induction of T‐cell apoptosis

A. Yamauchi, H. Hirai, S. Kimura, 2011, European journal of immunology.

Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer

F. Tanaka, S. Kimura, T. Yoshikawa, 2008, Molecular Cancer Therapeutics.

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.

H. Hirai, S. Kimura, T. Kiuchi, 2010, Cancer letters.

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model

J. Strovel, M. Taniwaki, Y. Hayashi, 2011, Blood cancer journal.

Administration of PLK1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer

F. Tanaka, S. Kimura, T. Yoshikawa, 2008 .

Multiple activation mechanisms of serotonin-mediated contraction in the carotid arteries obtained from spontaneously hypertensive rats

M. Takeuchi, K. Taguchi, Tsuneo Kobayashi, 2016, Pflügers Archiv - European Journal of Physiology.

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model

J. Strovel, M. Taniwaki, Y. Hayashi, 2011, Blood cancer journal.

Multiple activation mechanisms of serotonin-mediated contraction in the carotid arteries obtained from spontaneously hypertensive rats

M. Takeuchi, K. Taguchi, Tsuneo Kobayashi, 2016, Pflügers Archiv - European Journal of Physiology.

Inhibition of Wnt/β-Catenin Signaling by AV65 Treatment Caused Cell Cycle Arrest and Induced Caspase-Independent or -Dependent Apoptosis in CML Cells.

J. Strovel, H. Hirai, S. Kimura, 2009 .

A Novel β-catenin Inhibitor, AV65 Suppresses the Growth of CML Cell Lines Which Acquire Imatinib-Resistance Because of Abl Kinase Domain Mutations Including T315I and Hypoxia-Adaptation.

J. Strovel, S. Kimura, A. Yokota, 2008 .

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.

H. Hirai, S. Kimura, T. Kiuchi, 2010, Cancer letters.